TB Tourmaline Bio, Inc. Stock: price and insider trades · United States · SEC (Form 4)Track the Tourmaline Bio, Inc. share price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was reported on 28 October 2025 (U). Among the most active insiders: Kulkarni Sandeep Chidambar. All data is openly available.
Analyst consensus: bullish or bearish? Analysts rate Tourmaline Bio, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 October 2025
All Executives36 Thresholds0 Prospectus0 Other0
Declarations 36 total
● CFO · Executives · 28 Oct 2025
14,366 shares Common Stock SEC:0001997834-25-000006:0
● Director · Executives · 28 Oct 2025
83,782 shares Common Stock SEC:0001995535-25-000003:0
● Chief Technology Officer · Executives · 28 Oct 2025
19,782 shares Common Stock SEC:0001995339-25-000003:0
● Chief Regulatory Officer · Executives · 28 Oct 2025
40,538 shares Common Stock SEC:0001994710-25-000005:0
● CEO · Executives · 28 Oct 2025
724,664 shares Common Stock SEC:0001945691-25-000006:0
● Director · Executives · 28 Oct 2025
88,281 shares Common Stock SEC:0001862734-25-000006:0
● Director · Executives · 28 Oct 2025
518 shares Common Stock SEC:0001569226-25-000005:0
● Director · Executives · 28 Oct 2025
518 shares Common Stock SEC:0001242126-25-000005:0
● CBO, GC and Secretary · Executives · 28 Oct 2025
60,988 shares Common Stock SEC:0001214501-25-000004:0
● Director · Executives · 28 Oct 2025
515,997 shares Common Stock SEC:0001355758-25-000006:0
● Director · Executives · 28 Oct 2025
431,939 shares Common Stock SEC:0001355758-25-000006:1
● Director · Executives · 24 Oct 2025
5,000 shares 0Common Stock SEC:0001862734-25-000004:0
◇ CFO · Executives · 22 Oct 2025
14,366 shares @ US$13.92 100.0% of flow Common Stock SEC:0001997834-25-000004:0
◇ CEO · Executives · 22 Oct 2025
25,316 shares @ US$7.90 46.4% of flow Common Stock SEC:0001945691-25-000004:0
● Chief Regulatory Officer · Executives · 15 Oct 2025
6,250 shares 0Common Stock SEC:0001994710-25-000003:0
● Director · Executives · 15 Oct 2025
522 shares 0Common Stock SEC:0001355758-25-000004:0
◇ Director · Executives · 5 Sept 2025
37,890 shares @ US$0.13 4.8% of flow Common Stock SEC:0001415889-25-023997:0
▲ CEO · Executives · 21 Aug 2024
1,779 shares @ US$14.85 11.9% of flow Common Stock SEC:0001827506-24-000076:0
Canonical exit: 19 Nov 2024 (T+90) ▲ CEO · Executives · 16 Aug 2024
5,221 shares @ US$13.79 33.0% of flow Common Stock SEC:0001827506-24-000074:0
Canonical exit: 14 Nov 2024 (T+90) ▲ Director · Executives · 29 Jan 2024
100,000 shares @ US$32.50 100.0% of flow Common Stock SEC:0001415889-24-002069:0
Canonical exit: 28 Apr 2024 (T+90) ▲ Director · Executives · 17 Nov 2023
1,000 shares @ US$17.31 24.1% of flow Common Stock SEC:0001209191-23-056126:0
Canonical exit: 15 Feb 2024 (T+90) ▲ CEO · Executives · 17 Nov 2023
4,000 shares @ US$16.99 31.5% of flow Common Stock SEC:0001209191-23-056128:0
Canonical exit: 15 Feb 2024 (T+90) ▲ Director · Executives · 25 Oct 2023
4,200 shares @ US$12.07 100.0% of flow Common Stock SEC:0001209191-23-053791:0
Canonical exit: 23 Jan 2024 (T+90) ▲ Director · Executives · 24 Oct 2023
5,000 shares @ US$10.66 75.9% of flow Common Stock SEC:0001209191-23-053670:0
Canonical exit: 22 Jan 2024 (T+90) ▲ Director · Executives · 24 Oct 2023
7,500 shares @ US$11.86 100.0% of flow Common Stock SEC:0001209191-23-053674:0
Canonical exit: 22 Jan 2024 (T+90) 25 of 36 declarations
Load more (11 remaining) 关于 Tourmaline Bio, Inc. Tourmaline Bio, Inc. 是一家生物技术公司，专注于开发严重疾病的创新疗法。该公司在纳斯达克上市，股票代码为 TRML。